GlassScriptPhysician profile
Kristin M Ryan
NPI 1245443720
$4,599.59
in general payments reported to CMS, 2019-2025
9 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $181 · 2021: $330 · 2022: $96.75 · 2023: $143 · 2024: $2,851 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $1,435 · Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $1,435.17 |
| Food and Beverage | $550.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,124.46 | 2019-2025 | |
| Davol INC. | $660.37 | 2019-2025 | Phasix Mesh |
| Ethicon US, LLC | $331.42 | 2019-2021 | |
| Dexcom, INC. | $143.24 | 2023 | Dexcom G7 Gss (161) |
| Boston Scientific Corporation | $135.53 | 2024 | Spyglass Discover |
| Gilead Sciences, INC. | $96.75 | 2022 | |
| Olympus America INC. | $67.13 | 2019 | |
| Conmed Corporation | $23.66 | 2020 | |
| Merck Sharp & Dohme LLC | $17.03 | 2024 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.